I
Itzhak Brook
Researcher at Georgetown University
Publications - 453
Citations - 15719
Itzhak Brook is an academic researcher from Georgetown University. The author has contributed to research in topics: Anaerobic bacteria & Peptostreptococcus. The author has an hindex of 63, co-authored 448 publications receiving 14710 citations. Previous affiliations of Itzhak Brook include Boston Children's Hospital & University of Washington.
Papers
More filters
Journal ArticleDOI
Aerobic and anaerobic microbiology of superficial suppurative thrombophlebitis.
Itzhak Brook,Edith H. Frazier +1 more
TL;DR: The importance of anaerobic bacteria in superficial suppurative thrombophlebitis is illustrated through retrospective review of microbiologic and clinical data.
Journal ArticleDOI
Treatment of non-streptococcal tonsillitis with metronidazole
Itzhak Brook,Alan E. Gober +1 more
TL;DR: It is illustrated that metronidazole therapy was more efficacious than no therapy in relieving the signs and symptoms of acute episodes of NST and should encourage further studies that are prospective and blinded that are needed to evaluate the use of antimicrobials effective against anaerobic bacteria in the treatment of non-GABHS (group A-beta-hemolytic streptococcus) tonsillitis.
Journal ArticleDOI
Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir
Itzhak Brook,Alan E. Gober +1 more
TL;DR: Fever was reduced and GABHS was eradicated more rapidly from children treated with cefdinir as compared to amoxicillin.
Journal ArticleDOI
Recovery of anaerobic bacteria from a glossal abscess in an adolescent.
TL;DR: This report illustrates the recovery of anaerobic bacteria from glossal abscess in an adolescent with a 15-year-old patient presented with a tongue abscess following trauma.
Journal ArticleDOI
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice
TL;DR: In vivo data confirm the in vitro activity of these antimicrobials in the eradication of subcutaneous abscess in mice caused by Bacteroides fragilis group organisms and Escherichia coli alone or in combination.